Jingyou Pharmaceutical (00858.HK) plans to issue a total of 160 million shares for net proceeds to be used for the development of new businesses.

Wisdom Finance APP News, JY Pharmaceutical (00858.HK) announced that on August 14, 2025 (after trading hours), the company entered into a subscription agreement with subscriber I. According to this agreement, subscriber I has conditionally agreed to subscribe, while the company has conditionally agreed to issue and distribute a total of 30 million subscribed shares at a subscription price (totaling 2.91 million Hong Kong dollars, equivalent to 0.097 Hong Kong dollars per subscribed share). The subscription matters under subscription agreement I must be completed upon fulfillment of the conditions.